To invest for capital growth with no distribution target.The Fund aims to provide a consistent performance at low risk by investing in UK equities from the FTSE 350 Net Index.
Name | % Net Assets |
---|---|
Royal Dutch Shell | 9.7% |
BP | 8.8% |
HSBC | 6.2% |
GlaxoSmithKline | 6.1% |
Vodafone | 5.1% |
AstraZeneca | 4.4% |
British American Tobacco | 4.0% |
BHP Billiton | 3.2% |
Unilever (Consumer Goods) | 2.6% |
Tesco (Consumer Services) | 2.3% |
Key | % Net Assets |
---|---|
Royal Dutch Shell | 9.7% |
BP | 8.8% |
HSBC | 6.2% |
GlaxoSmithKline | 6.1% |
Other | 69.2% |
Date | 11-Aug-2014 |
---|---|
NAV | 17.83p |
Currency | GBP |
Change | -2.20p |
% | -1.02% |
YTD change | 17.83p |
YTD % | n/a |
Fund Inception | 01/06/1997 |
---|---|
Fund Manager | Michael Barakos / David Allen |
TER | 0.60 (30-Jun-2011) |
Minimum Investment | |
---|---|
Initial | £20000000 |
Additional | £100,000 |
Savings | £100 |
Charges | |
---|---|
Initial | 1.00% |
Annual Mang't | 0.60% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.07 |
You are here: research